76% of women needing fertility support lack access. Up to 77% of infertile women have excess weight and metabolic conditions that are treatable. The fertility-metabolic nexus rests at the intersection of massive, underserved markets — annual $10B women’s fertility, $480B women’s wellness, $72B weight management — yet there are essentially no options for women seeking safe and reliable care that optimizes fertility before conception, IVF, or pregnancy. This white paper reviews the landscape of women’s fertility in the US in Spring 2025 with a focus on the fertility-metabolic nexus opportunities ahead.

Link to fertility-metabolism nexus white paper -

Opportunity costs: MD in an MBA